Zinzino is very proud to announce the launch of India as the company’s next step in their global expansion strategy.
After several years of preparing the launch of the Indian market and having carried out multiple country establishment processes in recent years, the company has learned the importance of ensuring thorough preparatory work and adapting to the local conditions in each market.
Profitable growth is an important business strategy for the e-commerce-based health tech company Zinzino.
During 2020 the company sales target was exceeded by an excellent sales growth and a strong EBITA performance. The overall sales grew to 1.139 billion SEK ($132 million) from 771 million SEK ($89 million) in 2019.
“Strong growth provides economies of scale and increased profitability. This strengthens our faith in the future and creates great expectations for continued good profits going forward. India, with its huge population, is a very interesting and a high potential market for Zinzino,”
says CEO Dag Bergheim Pettersen.
Zinzino AB (publ.) is a global Direct Sales company that markets and sells test-based nutrition, skincare and life-style products. Zinzino owns the research unit BioActive Foods AS and production unit Faun Pharma AS.
Zinzino is based in Gothenburg, with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong and Malaysia. Zinzino is a public company and its shares are listed on Nasdaq First North Premier Growth Market. For more informaton please visit www.zinzino.com
Get more information, facts and figures about Zinzino, click here for the Zinzino overview.